Showing 3781-3790 of 9944 results for "".
Peri-ocular Rejuvenation and Nose Reform with Injectables
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/peri-ocular-rejuvenation-and-nose-reform-with-injectables/19393/Part of a live demonstration certification course on Advanced Live Patient Workshop I: Fillers: NASHAWDS 35th Anniversary Tribute
https://practicaldermatology.com/topics/practice-management/wds-35th-anniversary-tribute/19388/Rare Gems: Extraordinary Women in MedicineTattoo Removal
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/tattoo-removal--ponideho/19401/Dr. Amy Derick addresses tattoo removal through the latest laser technology.Audience Questions - Part 2
https://practicaldermatology.com/topics/practice-management/audience-questions-part-2/19489/Take 5
https://practicaldermatology.com/columns/take-5/0408_pd-take-5-pdf/22705/Take 5The First 5 Minutes with a Patient
https://practicaldermatology.com/series/pa-perspectives/first-5-minutes-patient/27105/In this video, Andrew Mastro, MS, PA-C, a board-certified physician assistant (PA) at the Illinois Dermatology Institute in Chicago, discusses the importance of crafting the right message during the first 5 minutes with a patient.DERM2020 Exhibitor Reaction: Brett Fair, EPI Health
https://practicaldermatology.com/conferences/dermatology-education-foundation-derm-2020/derm2020-exhibitor-reaction-brett-fair-epi-health/19847/Brett Fair of EPI Health, a DERM2020 exhibitor, tells us what he thinks of the new virtual meeting world and how DEF is dominating it for dermatology!FDA Approves Eli Lilly’s AD Drug Ebglyss (Lebrikizumab)
https://practicaldermatology.com/series/dermwire-tv/fda-approves-eli-lillys-ad-drug-ebglyss-lebrikizumab/28645/In this week's DermwireTV, Andrew F. Alexis, MD, Professor of Clinical Dermatology at Weill Cornell Medical College, discusses the newly approved AD drug lebrikizumab; LEO Pharma announces two major regulatory milestones for its chronic hand eczema (CHE) treatment; and the CMO of Arcutis BioteherapuEvaluating GEP Test Options
https://practicaldermatology.com/programs/practical-dermatology/evaluating-gep-test-options/35600/David Cotter, MD, a board-certified dermatologist, discusses what he looks for in a gene expression profile (GEP) test, including the types of clinical evidence that are most important.COVID-19 Impact: iPledge and Isotretinoin Prescribing
https://practicaldermatology.com/topics/acne-rosacea/covid-19-impact-ipledge-and-isotretinoin-prescribing/19763/For patients on isotretinoin, complying with the iPledge program while treating patients virtually can be challenging. Joshua Zeichner, MD discusses new FDA guidance that allows female patients to take OTC pregnancy tests in order to continue treatment. He also discusses when patients do and do not